MyChoice CDx
For patients with ovarian cancer, MyChoice® CDx examines an ovarian cancer tumor’s HRD status to help determine whether a patient may be a candidate for PARP inhibitor therapy.
mutation createOrder {
createOrder(order: {
requisitionNumber: "SOME_REQUISITION_NUMBER"
patient: {
firstName: "John"
lastName: "Doe"
dob: "1960-01-01"
genderCode: MALE
address: {
street: "320 Wakara Way"
city: "Salt Lake City"
stateCode: UT
postalCode: "84104"
}
mobilePhoneNumber: "801-584-3700"
emailAddress: "test@myriad.com"
}
products: [
{
product: MYCHOICE
}
]
clinical: {
boneMarrowTransplantRecipient: AUTOLOGOUS
personalCancerHistory: [{
ovarian: {
diagnosisAge: 40
currentlyBeingTreated: true
diagnosisDetails: {
left: true
right: false
additionalHistopathology: "Some String"
}
}
}]
familyCancerHistory: [{
relationshipTypeCode: MOTHER
cancerHistory: [{
cancerSiteCode: OVARIAN
diagnosisAge: {
age: 60
}
}]
}]
ancestry: [
ASHKENAZI_JEWISH
]
}
billing: {
institution: {
institutionalAccountNumber: "12345"
}
}
specimens: [{
tumor: {
collectionDate: "2024-01-01"
hospitalizationCode: HOSPITAL_INPATIENT
hospitalDischargeDate: "2024-01-01"
tumorStage: I
tissueTypeCode: OVARY
specimenIds: ["Your ID"]
currentTreatment: [NOT_STARTED]
previousTreatment: [CHEMOTHERAPY]
tumorClinicalStatus: [REFRACTORY]
tumorHistory: {
ovarian: {
diagnosisAge: 40
currentlyBeingTreated: true
diagnosisDetails: {
left: true
right: false
additionalHistopathology: "Some String"
}
}
}
}
}]
providerAccounts: [
{
organization: {
identifiers: {
use: OFFICIAL
type: XX
value: "SOME_ORGANIZATION_ID_PROVIDED_MYRIAD"
}
}
provider: {
identifiers: [
{
use: OFFICIAL
type: NPI
value: "SOME_NPI"
}
]
firstName: "John"
lastName: "Smith"
}
role: ORDERING
location: {
identifiers: [
{
use: OFFICIAL
type: FI
value: "SOME_ORDERING_PROVIDER_ID_PROVIDED_MYRIAD"
}
]
}
}
]
notes: [
"this is a test note"
]
}) { id }
}